Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Metal-On-Metal Hip Resurfacing Must Meet Revision Criteria – UK’s NICE

This article was originally published in The Gray Sheet

Executive Summary

Additional data on metal-on-metal hip operations should be established as part of a UK national joint registry, the National Institute for Clinical Excellence advises in its final guidance recommending selective use of MoM resurfacing devices

You may also be interested in...



UK National Joint Registry Levy Will Be Collected By Device Trade Group

A steering committee is being formed to set the terms of a tax to fund the UK's National Joint Registry for Hip and Knee Replacements (NJR). The registry fee will be collected by the Association of British Healthcare Industries

UK National Joint Registry Levy Will Be Collected By Device Trade Group

A steering committee is being formed to set the terms of a tax to fund the UK's National Joint Registry for Hip and Knee Replacements (NJR). The registry fee will be collected by the Association of British Healthcare Industries

Appraisal Consultation Document NICE For Metal-On-Metal Hip Manufactures

Metal-on-metal hip resurfacing arthroplasty is an acceptable alternative to total hip replacement (THR) for active, younger patients with advanced hip disease, a preliminary report by the UK's National Institute for Clinical Excellence concludes

Latest Headlines
See All
UsernamePublicRestriction

Register

MT016774

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel